Everybody Can’t Be Allowed To Prescribe Medicines For Treatment, Says SC

New Delhi : Everybody cannot be allowed to prescribe medicines, observed the Supreme Court on Thursday while hearing an appeal against the Kerala High Court order which had said that AYUSH medical practitioners can prescribe government approved mixtures and tablets only as immunity booster for COVID-19.

A bench headed by Justice Ashok Bhushan asked Solicitor General Tushar Mehta to file counter affidavit within a week on the plea against the August 21 order of the high court. The apex court asked Mehta whether there are any guidelines in this regard by the Ministry of AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy).

The solicitor general said that he would place on record the guidelines on this aspect. As prayed, one week time is granted. List after a week, the bench said in its order. During the hearing, the bench, also comprising Justices R S Reddy and M R Shah, said, Everybody can’t be allowed to prescribe medicines, and It may be used as immunity booster but not for treatment.

The high court had passed the order on a plea which had sought a direction to the state authority to ensure that homoeopathic practitioners are immediately allowed to perform in accordance with the March 6 notification of the Ministry of AYUSH, which had said that state government shall take steps to adopt homoeopathic system among other systems of medicines in the fight against the menace of Coronavirus.

Advisory of the Ministry of AYUSH is being followed by the government and tablets are given free of cost to those persons as immunity boosters. As per the state medical protocol, COVID-19 affected persons should not be treated by anybody other than the government and those authorised by the government, the high court had noted in its order.

The high court had further noted that as per the medical protocol of the government, doctors practising in AYUSH medicines are not supposed to prescribe any medicines stating that it is curative for COVID-19 disease.

However, as per the advisory, there is nothing prohibiting the qualified medical AYUSH practitioners to prescribe immunity booster mixture or tablets, as suggested by the Ministry of AYUSH, Government of India, New Delhi, it had said.

When the Central as well as State Governments have approved prescription of certain mixtures and tablets, as immunity boosters, qualified medical practitioners in AYUSH can also prescribe the same, but only as immunity boosters, the high court had noted in its order.

Reference: Dr. AKB Sadbhavana Mission School of Homoeo Pharmacy vs The Secretary, Ministry of Ayush & Ors., Supreme Court of India, SLP (Civil) Diary No(s) 19638/2020, D/h 19.11.2020

Related Posts

Supreme Court declines plea to make nucleic acid tests compulsory at blood banks

New Delhi:  The Supreme Court on Friday (March 13, 2026) refused to direct the government to compulsorily conduct “expensive” Nucleic Acid Tests (NAT) to identify diseases ahead of blood transfusions,…

Jaipur: Fraudster Arun Kumar Arrested for Extorting Medical Store Owners by Posing as Drug Inspector

Jaipur— Brahmpuri police in Jaipur have arrested a notorious fraudster who systematically extorted money from medical store owners by impersonating a Drug Inspector. The same accused, Arun Kumar, also cheated…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Supreme Court declines plea to make nucleic acid tests compulsory at blood banks

Supreme Court declines plea to make nucleic acid tests compulsory at blood banks

Jaipur: Fraudster Arun Kumar Arrested for Extorting Medical Store Owners by Posing as Drug Inspector

Jaipur: Fraudster Arun Kumar Arrested for Extorting Medical Store Owners by Posing as Drug Inspector

India’s Medical Devices Sector Logs 4,108 Licensed Manufacturers and ₹20,658 Crore FDI Inflows Since 2018

India’s Medical Devices Sector Logs 4,108 Licensed Manufacturers and ₹20,658 Crore FDI Inflows Since 2018

Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India

Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India

Top 30 pharma companies post 12% revenue growth in first nine months

Top 30 pharma companies post 12% revenue growth in first nine months

India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory

India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory